Page 85 - 南京医科大学自然版
P. 85

第46卷第6期              陈冠宇,张泽楷,龚        袁,等. 肥胖共患中枢性性早熟女童的脂质组学分析[J].
                  2026年6月                      南京医科大学学报(自然科学版),2026,46(6):864-872                      ·867  ·


                                               表1 CO⁃CPP组与CO⁃PPP组基本信息比较
                              Table 1 Comparison of basic information between the CO⁃CPP group and CO⁃PPP group
                         Variable              CO⁃CPP(n=10)          CO⁃PPP(n=10)       Test Statistics   P
                  Age(years,x ± s)               7.38 ± 0.62          07.12 ± 0.65        t=2.093        0.051
                  Height(cm,x ± s)             136.39 ± 6.960        127.75 ± 4.430       t=3.310        0.004
                  HAZ[M(P25,P75)]           002.04(1.09,2.60)      00.97(0.16,1.86)       z=-1.965       0.049
                  Weight(kg,x ± s)              38.74 ± 4.350         35.17 ± 3.08        t=2.119        0.048
                  WAZ(x ± s)                     2.56 ± 0.49          02.50 ± 0.69        t=0.210        0.836
                  BMI(kg/m ,x ± s)              20.74 ± 1.920         21.58 ± 2.17        t=-0.918       0.371
                          2
                  BAZ(x ± s)                     2.11 ± 0.52          02.49 ± 0.79        t=-1.272       0.220
                  BA[years,M(P25,P75)]      010.25(8.98,11.0)      08.45(6.80,8.80)       z=-3.053       0.002
                  BAI[M(P25,P75)]           000.33(0.18,0.40)      00.18(0.06,0.25)       z=-2.427       0.015
                  IGF⁃1(ng/mL,x ± s)           273.11 ± 111.87       208.80 ± 52.62       t=1.645        0.117
                  LH[IU/L,M(P25,P75)]       001.14(0.32,4.00)      00.13(0.06,0.27)       z=-3.408      <0.001
                  FSH[IU/L,M(P25,P75)]      003.35(2.30,5.99)      01.68(0.52,2.80)       z=-2.117       0.034
                  E2[pg/mL,M(P25,P75)]      013.65(8.55,41.50)     04.97(2.80,15.78)      z=-1.965       0.046
                  OV[mL,M(P25,P75)]         004.08(2.44,5.72)      02.26(1.35,3.18)       z=-2.192       0.029
                  PRL[ng/mL,M(P25,P75)]     010.66(6.34,15.30)     09.01(5.54,18.53)      z=0.000        1.000
                  UV(mL,x ± s)                   2.84 ± 1.05          01.11 ± 0.61        t=4.496       <0.001
                  FPG(mmol/L,x ± s)              5.18 ± 0.47          04.66 ± 0.53        t=2.270        0.036
                  TG[mmol/L,M(P25,P75)]     000.82(0.59,1.29)      00.64(0.53,0.82)       z=-1.209       0.226
                  ALT[U/L,M(P25,P75)]       013.00(5.00,21.00)     12.00(2.60,21.40)      z=-0.303       0.762
                  AST[U/L,M(P25,P75)]       020.30(15.60,25.00)    21.60(18.20,25.00)     z=-0.756       0.450
                  INS[pmol/L,M(P25,P75)]    114.45(55.70,147.25)   63.05(43.90,85.27)     z=-1.663       0.096
                  TBIL[μmol/L,M(P25,P75)]   007.80(5.40,10.20)     07.90(5.00,10.80)      z=-0.113       0.910



                A                         B                                           C
                                                       Type  CO⁃CPP  CO⁃PPP  QC         QCs RSD coverage
                   (lg)  10                                                               <10%    >20%-30%
                                                                                                   >30%
                                                                                          10%-15%
                                                                                                        >15%-20%
                   Lipid intensity  8 6      (intensity)  30                                       106(6.4%)
                                                                                                       52(3.2%)
                                                                                                          81(5%)
                                             20
                      0   500  1 000 1 500   log2  10                                               183(11.3%)
                            Lipid rank           A1  A10  A2  A3  A4  A5  A6  A7  A8  A9  B1  B10  B2  B3  B4  B5  B6  B7  B8  B9  QC1  QC2  QC3  1 194(74%)
                                                                Sample


                   A:Quantitative intensity sequencing analysis. B:Distribution of lipid quantification values. C:The proportion of response intensity RSD corre⁃
                sponding to spectral peaks in the quality control sample,with the purple portion excluded.
                                             图1 CO⁃CPP组与CO⁃PPP组脂质定量分析比较
                          Figure 1  Comparison of lipid quantitative analysis between the CO⁃CPP group and CO⁃PPP group

                指标及联合指标的AUC,提示判别效能提升。
                                                                  3  讨 论
                    选取 Cer 与 LH 基础值行二元 Logistic 回归分析
                显示 Omnibus 检验显著性水平 P < 0.001,Nagelker⁃                近半个世纪以来,随着全球经济的快速发展及
                                                                                                     [2]
                ke R 为 0.807,Hosmer⁃Lemeshow 检验 P 值 0.773,提       饮食结构的变化,儿童肥胖率持续攀升 。大量流
                    2
                示该模型整体显著,拟合效果良好,但变量系数提                            行病学及临床研究证实,肥胖是儿童发生CPP 的重
                示无统计学意义(P > 0.05,表4)。                             要独立危险因素之一          [6-7] 。揭示二者共病的生物学
   80   81   82   83   84   85   86   87   88   89   90